0001140361-24-016154.txt : 20240328 0001140361-24-016154.hdr.sgml : 20240328 20240328162125 ACCESSION NUMBER: 0001140361-24-016154 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240328 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240328 DATE AS OF CHANGE: 20240328 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Forian Inc. CENTRAL INDEX KEY: 0001829280 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] ORGANIZATION NAME: 06 Technology IRS NUMBER: 853467693 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40146 FILM NUMBER: 24799296 BUSINESS ADDRESS: STREET 1: 41 UNIVERSITY DRIVE STREET 2: SUITE 400 CITY: NEWTOWN STATE: PA ZIP: 18940 BUSINESS PHONE: 267-757-8707 MAIL ADDRESS: STREET 1: 41 UNIVERSITY DRIVE STREET 2: SUITE 400 CITY: NEWTOWN STATE: PA ZIP: 18940 8-K 1 ef20023970_8k.htm 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):  March 28, 2024

FORIAN INC.
(Exact Name of Registrant as Specified in Charter)

Delaware
001-40146
85-3467693
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

 
41 University Drive, Suite 400, Newtown, PA
  
 
18940
(Address of principal executive offices)
  
(Zip Code)

Registrant’s telephone number, including area code:  (267) 225-6263

 (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐
 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐
 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.001 par value
FORA
The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).  ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Item 2.02
Results of Operations and Financial Condition

On March 28, 2024, Forian Inc. issued a press release announcing its financial results for the quarter and full year ended December 31, 2023. A copy of the press release is furnished herewith as Exhibit 99.1.

The information furnished in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such a filing.

Item 9.01
Financial Statements and Exhibits

(d)
Exhibits.

The Company hereby files or furnishes, as applicable, the following exhibits:

Exhibit No.
  
Description
     
 
Press Release, dated March 28, 2024 (furnished herewith)
     
104
  
Cover Page Interactive Data File (embedded within the Inline XBRL document)

2
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
FORIAN INC.
     
 Dated: March 28, 2024
By:
/s/ Edward Spaniel, Jr.
 
Name:
Edward Spaniel, Jr.
 
Title:
Executive Vice President, General Counsel and Secretary


3
 EX-99.1 2 ef20023970_ex99-1.htm EXHIBIT 99.1
Exhibit 99.1


Forian Inc.
Announces Fourth Quarter and Full Year 2023 Financial Results

Full year 2023 revenue grew 25%
Full year 2023 Adjusted EBITDA of $2.3MM

Newtown, PA, March 28, 2024 (GLOBE NEWSWIRE) – via NewMediaWire – Forian Inc. (Nasdaq: FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced results for the quarter and year ended December 31, 2023.

“Forian finished the year by executing against our quarterly plan and closed what was a transformational year,” stated Max Wygod, Chairman and Chief Executive Officer of Forian. “In 2023, we successfully completed a major divestiture and refocused our business on healthcare and life sciences, continued revenue growth and achieved Adjusted EBITDA ahead of schedule.”

Fourth Quarter 2023 Financial Results

Forian delivered the following results for the fourth quarter of 2023:

   
Three Months Ended December 31,
  
     
  
2023
Unaudited

 
2022
Unaudited

Period-over-
Period %
Change
Revenue
  
$
5,368,932
    
$
4,969,673
      
    8%
                       
Loss from continuing operations, net of tax
  
$
(381,014
)
  
$
(1,900,105
)
    
  80%
Income (loss) from discontinued operations, net of tax
  
$
1,769,957
    
$
(1,656,609
)
    
207%
Net Income (loss)
  
$
1,388,943
    
$
(3,556,714
)
    
139%
                       
Loss from continuing operations, net of tax per share - diluted
  
$
(0.01
)
  
$
(0.06
)
    
  83%
Income (loss) from discontinued operations, net of tax per share - diluted
  
$
0.05
    
$
(0.05
)
    
200%
Income (loss) per share - diluted
  
$
0.04
    
$
(0.11
)
    
136%
                       
Adjusted EBITDA (a non-GAAP financial measure defined below)
  
$
1,033,648
    
$
(425,434
)
    
343%


●
Revenue for the quarter was $5.4 million, an increase of $0.4 million versus the prior year

●
Net loss from continuing operations for the quarter was $0.4 million, or $0.01 per share, compared to a net loss of $1.9 million, or $0.06 per share, in the prior year

●
Adjusted EBITDA1 for the quarter was $1.0 million, compared to negative $0.4 million in the prior year

●
Cash, cash equivalents and marketable securities at December 31, 2023 totaled $48.3 million

Full Year 2023 Financial Results

Forian delivered the following results for the full year 2023:
 
   
Twelve Months Ended December 31,
  
     
  
2023
Unaudited

 
2022
Unaudited

Period-over-
Period %
Change
Revenue
  
$
20,481,330
    
$
16,418,141
      
  25%
                       
Income (loss) from continuing operations, net of tax
  
$
1,733,430
    
$
(19,191,990
)
    
109%
Income (loss) from discontinued operations, net of tax
  
$
9,373,257
    
$
(6,779,981
)
    
238%
Net Income (loss)
  
$
11,106,687
    
$
(25,971,971
)
    
143%
                       
Income (loss) from continuing operations, net of tax per share - diluted
  
$
0.05
    
$
(0.60
)
    
108%
Income (loss) from discontinued operations, net of tax per share - diluted
  
$
0.29
    
$
(0.21
)
    
238%
Income (loss) per share - diluted
  
$
0.34
    
$
(0.81
)
    
142%
                       
Adjusted EBITDA (a non-GAAP financial measure defined below)
  
$
2,336,380
    
$
(6,707,809
)
    
135%


●
Revenue for the full year was $20.5 million, an increase of $4.1 million versus the prior year

●
Net income from continuing operations for the full year was $1.7 million, or $0.05 per share, compared to a loss of $19.2 million, or $0.60 per share, in the prior year

●
Adjusted EBITDA1 for the full year was $2.3 million, compared to negative $6.7 million in the prior year

Full Year 2023 Highlights


 ●
Divested BioTrack to focus solely on our core healthcare and life sciences business, enhancing our ability to deliver innovation and value to our clients

●
Grew revenue and met guidance in a difficult macroeconomic environment

●
Achieved our positive Adjusted EBITDA1 milestone faster than was projected and demonstrated sequential margin improvement

●
Expanded and extended our data sources to include more open and closed claims data, new lab data and the development of high value physician reference data

●
Repurchased 1.6 million shares of Forian common stock in a privately negotiated transaction at a redemption price of $2.15 per share

●
Repurchased approximately $1 million of our outstanding convertible notes in October 2023 and an additional $1 million in March 2024 in privately negotiated transactions

Full Year 2024 Outlook

Based on information as of March 28, 2024, the Company is sharing the following outlook for the year ending December 31, 2024:


 ●
Revenue growth is expected to be in the range of 5% to 15%

●
Adjusted EBITDA1 margin is expected to be in the range of 8% to 12%

1 This release uses non-GAAP financial measures that are adjusted for the impact of various U.S. GAAP items. See the section titled “Non-GAAP Financial Measures” and the table entitled “Reconciliation of U.S. GAAP to Non-GAAP Financial Measures” below for details.

Quarterly Conference Call and Webcast

Forian will host a conference call and webcast at 4:30 p.m. ET on March 28, 2024 to discuss its financial results with the investment community. To register for the conference call, click here. The webcast will be available live at https://edge.media-server.com/mmc/p/w4vcipvu. This information is also available on our website at www.forian.com/investors. To be included on the Company’s email distribution list, please sign up at www.forian.com/investors.

About Forian
Forian provides a unique suite of data management capabilities and proprietary information and analytics solutions to optimize and measure operational, clinical and financial performance for customers within the traditional and emerging life sciences and healthcare payer and provider segments. Forian has industry leading expertise in acquiring, integrating, normalizing and commercializing large scale healthcare data assets. Forian’s information products overlay sophisticated data management and data science capabilities on top of a comprehensive clinical data lake to identify unique relationships, create distinctive information assets and generate proprietary insights. For more information, please visit the Company’s website at www.forian.com.

Cautionary Statements Regarding Forward-Looking Statements
This release contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, which may include GAAP and non-GAAP financial measures, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions and variations or negatives of these words. Forward-looking statements by their nature address matters that involve risks and uncertainties, many of which are beyond our control and are not guarantees of future results, such as statements about future financial and operating results, company strategy and intended product offerings and market positioning. These and other forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in such statements and, therefore, you should not place undue reliance on any such statements and caution must be exercised in relying on forward-looking statements. Factors that could cause actual results to differ include, but are not limited to, those risks and uncertainties associated with operations, strategy and goals, our ability to execute on our strategy and the additional risks and uncertainties set forth more fully under the caption “Risk Factors” in Forian’s Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the SEC on March 30, 2023, and elsewhere in Forian’s filings and reports with the SEC. Forward-looking statements contained in this release are made as of the date hereof, and we undertake no duty to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable law.

Media and Investor Contact:
forian.com/investors
ir@forian.com
267-225-6263
SOURCE: Forian Inc.

FORIAN INC.
CONDENSED CONSOLIDATED BALANCE SHEETS

     
December 31,
2023
      
December 31,
2022
   
   
(UNAUDITED)
        
ASSETS
            
Current assets:
            
Cash and cash equivalents
  
$
6,042,986
    
$
2,795,743
  
Marketable securities
    
42,296,589
      
17,396,487
  
Accounts receivable, net
    
2,572,931
      
1,809,028
  
Proceeds receivable from sale of discontinued operation, net
    
1,645,954
      
-
  
Contract assets
    
1,126,713
      
2,252,958
  
Prepaid expenses
    
1,077,233
      
835,786
  
Other assets
    
2,515,509
      
432,338
  
Current assets of discontinued operations
    
-
      
1,393,688
  
Total current assets
    
57,277,915
      
26,916,028
  
                 
Property and equipment, net
    
76,085
      
75,030
  
Right of use assets, net
    
10,664
      
32,560
  
Deposits and other assets
    
1,523,948
      
196,675
  
Non current assets of discontinued operations
    
-
      
19,037,874
  
Total assets
  
$
58,888,612
    
$
46,258,167
  
                 
LIABILITIES AND STOCKHOLDERS' EQUITY
                
Current liabilities:
                
Accounts payable
  
$
161,590
    
$
316,105
  
Accrued expenses
    
4,252,257
      
3,766,789
  
Short-term operating lease liabilities
    
10,664
      
21,600
  
Warrant liability
    
563
      
4,547
  
Deferred revenues
    
2,413,551
      
2,581,287
  
Current liabilities of discontinued operations
    
-
      
1,662,247
  
Total current liabilities
    
6,838,625
      
8,352,575
  
                 
Long-term liabilities:
                
Other liabilities
    
1,000,000
      
10,960
  
Convertible notes payable, net of debt issuance costs ($6,000,000 in principal is held by a related party)
    
24,870,181
      
25,106,547
  
Non current liabilities of discontinued operations
    
-
      
365,609
  
Total long-term liabilities
    
25,870,181
      
25,483,116
  
 
                
Total liabilities
    
32,708,806
      
33,835,691
  
                 
Commitments and contingencies
                
Stockholders' equity:
                
Preferred Stock; par value $0.001; 5,000,000 Shares authorized; 0 issued and outstanding as of December 31, 2023 and December 31, 2022
    
-
      
-
  
Common Stock; par value $0.001; 95,000,000 Shares authorized; 30,920,450 issued and outstanding as of  December 31, 2023 and 32,251,326 issued and outstanding as of December 31, 2022
    
30,920
      
32,251
  
Additional paid-in capital
    
73,834,300
      
71,182,326
  
Accumulated deficit
    
(47,685,414
)
    
(58,792,101
)
Total stockholders' equity
    
26,179,806
      
12,422,476
  
Total liabilities and stockholders' equity
  
$
58,888,612
    
$
46,258,167
  

FORIAN INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)

   
For the Three Months Ended
December 31,
    
For the Years Ended
December 31,
  
   
2023
    
2022
    
2023
    
2022
  
                         
Revenue
  
$
5,368,932
    
$
4,969,673
    
$
20,481,330
    
$
16,418,141
  
                                 
Costs and Expenses:
                                
Cost of revenue
    
1,585,550
      
1,196,215
      
5,477,032
      
5,049,701
  
Research and development
    
306,923
      
694,263
      
1,407,580
      
4,009,769
  
Sales and marketing
    
1,137,536
      
1,044,668
      
4,884,267
      
3,949,026
  
General and administrative
    
3,240,177
      
3,876,700
      
13,633,193
      
16,879,858
  
Separation expenses
    
-
      
-
      
599,832
      
5,417,043
  
Depreciation and amortization
    
10,153
      
16,955
      
74,438
      
65,554
  
Total costs and expenses
    
6,280,339
      
6,828,801
      
26,076,342
      
35,370,951
  
                                 
Operating loss From Continuing Operations
    
(911,407
)
    
(1,859,128
)
    
(5,595,012
)
    
(18,952,810
)
                                 
Other Income (Expense):
                                
Change in fair value of warrant liability
    
(104
)
    
21,532
      
3,984
      
364,687
  
Interest and investment income
    
661,188
      
154,530
      
2,327,974
      
266,213
  
Gain on sale of investment
    
-
      
-
      
5,805,858
      
-
  
Interest expense
    
(204,238
)
    
(213,059
)
    
(834,785
)
    
(846,100
)
Gain on debt redemption
    
-
      
-
      
111,151
      
-
  
Total other income (expense), net
    
456,846
      
(36,997
)
    
7,414,182
      
(215,200
)
                                 
(Loss) income from continuing operations before income taxes
    
(454,561
)
    
(1,896,125
)
    
1,819,170
      
(19,168,010
)
Income taxes
    
73,547
      
(3,980
)
    
(85,740
)
    
(23,980
)
(Loss) income from continuing operations, net of tax
    
(381,014
)
    
(1,900,105
)
    
1,733,430
      
(19,191,990
)
                                 
Loss from discontinued operations
    
-
      
(1,487,382
)
    
(94,427
)
    
(6,812,913
)
(Loss) gain on sale of discontinued operations
    
-
      
(169,227
)
    
11,531,849
      
32,932
  
Income tax effect on discontinued operations
    
1,769,957
      
-
      
(2,064,165
)
    
-
  
Income (loss) from discontinued operations, net of tax
    
1,769,957
      
(1,656,609
)
    
9,373,257
      
(6,779,981
)
Net income (loss)
  
$
1,388,943
    
$
(3,556,714
)
  
$
11,106,687
      
$(25,971,971)
  
                                 
Net income (loss) per share
                                
Basic
                                
Continuing operations
  
$
(0.01
)
  
$
(0.06
)
  
$
0.05
    
$
(0.60
)
Discontinued operations
  
$
0.05
    
$
(0.05
)
  
$
0.29
    
$
(0.21
)
Net income (loss) per share - basic
  
$
0.04
    
$
(0.11
)
  
$
0.34
    
$
(0.81
)
                                 
Diluted
                                
Continuing operations
  
$
(0.01
)
  
$
(0.06
)
  
$
0.05
    
$
(0.60
)
Discontinued operations
  
$
0.05
    
$
(0.05
)
  
$
0.29
    
$
(0.21
)
Net income (loss) per share - diluted
  
$
0.04
    
$
(0.11
)
  
$
0.34
    
$
(0.81
)
                                 
Weighted-average shares outstanding- basic
    
32,459,838
      
32,088,358
      
32,030,855
      
32,031,096
  
                                 
Weighted-average shares outstanding- diluted
    
32,459,838
      
32,088,358
      
32,230,845
      
32,031,096
  

FORIAN INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)

   
For the Years Ended December 31,
  
   
2023
    
2022
  
CASH FLOWS FROM OPERATING ACTIVITIES:
            
Net income (loss)
  
$
11,106,687
    
$
(25,971,971
)
Less: Income (loss) from discontinued operations
    
9,373,257
      
(6,779,981
)
Income (loss) from continuing operations
    
1,733,430
      
(19,191,990
)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities - continuing operations:
                
Depreciation and amortization
    
74,438
      
65,554
  
Amortization on right of use asset
    
21,896
      
1,627
  
Amortization of debt issuance costs
    
5,333
      
5,333
  
Accrued interest on Convertible Notes
    
829,452
      
840,767
  
Amortization of discount - proceeds from sale of discontinued operations
    
(389,288
)
    
-
  
Accretion of discount - marketable securities
    
(1,876,085
)
    
(265,443
)
Gain on sale of investment
    
(5,805,858
)
    
-
  
Gain on debt redemption
    
(111,151
)
    
-
  
Stock-based compensation expense
    
6,573,969
      
11,920,575
  
Change in fair value of warrant liability
    
(3,984
)
    
(364,687
)
Change in operating assets and liabilities:
                
Accounts receivable
    
(763,903
)
    
(775,451
)
Contract assets
    
1,126,245
      
(1,196,067
)
Prepaid expenses
    
(241,447
)
    
2,382
  
Changes in lease liabilities during the period
    
(21,896
)
    
28,911
  
Deposits and other assets
    
(1,520,022
)
    
496,485
  
Accounts payable
    
(154,521
)
    
(131,368
)
Accrued expenses
    
479,021
      
548,634
  
Deferred revenues
    
(167,736
)
    
1,943,724
  
Other liabilities
    
1,000,000
      
-
  
Net cash provided by (used in) operating activities - continuing operations
    
787,893
      
(6,071,014
)
Net cash used in operating activities - discontinued operations
    
(59,075
)
    
(2,510,160
)
Net cash provided by (used in) operating activities
    
728,818
      
(8,581,174
)
                 
CASH FLOWS FROM INVESTING ACTIVITIES:
                
Additions to property and equipment
    
(75,493
)
    
(47,678
)
Purchase of marketable securities
    
(144,077,731
)
    
(55,819,346
)
Sale of marketable securities
    
121,053,714
      
51,087,663
  
Proceeds from sale of investment
    
5,805,858
      
-
  
Cash from sale of discontinued operations
    
24,413,595
      
(17,906
)
Net cash provided by (used in) provided by investing activities - continuing operations
    
7,119,943
      
(4,797,267
)
Net cash used in investing activities - discontinued operations
    
-
      
(1,663,778
)
Net cash provided by (used in) investing activities
    
7,119,943
      
(6,461,045
)
 
                
CASH FLOWS FROM FINANCING ACTIVITIES:
                
Payments on notes payable and financing arrangements
    
-
      
(13,122
)
Repurchase of common stock
    
(3,450,053
)
        
Cash used to redeem convertible notes
    
(960,000
)
    
-
  
Payment of employee withholding tax related to restricted stock units
    
(191,465
)
    
(87,406
)
Net cash used in financing activities- continuing operations
    
(4,601,518
)
    
(100,528
)
Net cash used in financing activities
    
(4,601,518
)
    
(100,528
)
 
                
Net change in cash
    
3,247,243
      
(15,142,747
)
                 
Cash and cash equivalents, beginning of period
    
2,795,743
      
17,938,490
  
                 
Cash and cash equivalents, end of period
  
$
6,042,986
    
$
2,795,743
  
                 
Supplemental disclosure of cash flow information
                
Cash paid for interest
  
$
-
    
$
-
  
Cash paid for taxes
  
$
4,066,385
    
$
18,444
  

Non-GAAP Financial Measures

In this press release, we have provided certain non-GAAP measures, which we define as financial information that has not been prepared in accordance with U.S. GAAP. The non-GAAP financial measure provided herein is earnings before interest, taxes, non-cash and other items (“Adjusted EBITDA”), which should be viewed as supplemental to, and not as an alternative for, net income or loss calculated in accordance with U.S. GAAP (referred to below as “net loss”).

Adjusted EBITDA is used by our management as an additional measure of our Company’s performance for purposes of business decision-making, including developing budgets, managing expenditures and evaluating potential acquisitions or divestitures. Period-to-period comparisons of Adjusted EBITDA help our management identify additional trends in our Company’s financial results that may not be shown solely by period-to-period comparisons of net income. In addition, we may use Adjusted EBITDA in the incentive compensation programs applicable to some of our employees in order to evaluate our Company’s performance. Our management recognizes that Adjusted EBITDA has inherent limitations because of the excluded items, particularly those items that are recurring in nature. In order to compensate for those limitations, management also reviews the specific items that are excluded from Adjusted EBITDA, but included in net income, as well as trends in those items.

We believe that the presentation of Adjusted EBITDA is useful to investors in their analysis of our results for reasons similar to the reasons why our management finds it useful and because it helps facilitate investor understanding of decisions made by management in light of the performance metrics used in making those decisions. In addition, as more fully described below, we believe that providing Adjusted EBITDA, together with a reconciliation of net loss to Adjusted EBITDA, helps investors make comparisons between our Company and other companies that may have different capital structures, different effective income tax rates and tax attributes, different capitalized asset values and/or different forms of employee compensation. However, Adjusted EBITDA is not intended as a substitute for comparisons based on net loss. In making any comparisons to other companies, investors need to be aware that companies use different non-GAAP measures to evaluate their financial performance. Investors should pay close attention to the specific definition being used and to the reconciliation between such measures and the corresponding U.S. GAAP measures provided by each company under applicable SEC rules.

The following is an explanation of the items excluded from Adjusted EBITDA but included in net loss from continuing operations:


 •
Depreciation and Amortization. Depreciation and amortization expense is a non-cash expense relating to capital expenditures and intangible assets arising from acquisitions that are expensed on a straight-line basis over the estimated useful life of the related assets. The Company excludes depreciation and amortization expense from Adjusted EBITDA because management believes that (i) the amount of such expenses in any specific period may not directly correlate to the underlying performance of the business operations and (ii) such expenses can vary significantly between periods as a result of new acquisitions and full amortization of previously acquired tangible and intangible assets. Accordingly, management believes that this exclusion assists management and investors in making period-to-period comparisons of operating performance. Investors should note that the use of tangible and intangible assets contributed to revenue in the periods presented and will contribute to future revenue generation and should also note that such expense will recur in future periods.


•
Stock-Based Compensation Expense. Stock-based compensation expense is a non-cash expense arising from the grant of stock-based awards to employees. Management believes that excluding the effect of stock-based compensation from Adjusted EBITDA assists management and investors in making period-to-period comparisons in the Company’s operating performance because (i) the amount of such expenses in any specific period may not directly correlate to the underlying performance of business operations and (ii) such expenses can vary significantly between periods as a result of the timing of grants of new stock-based awards, including grants in connection with acquisitions. Stock-based compensation expense includes certain separation expenses related to the vesting of stock options. Effective February 10, 2023, the Company’s Chief Executive Officer, President and Class II member of the Board of Directors resigned. In connection with the resignation, the Company entered into a separation agreement providing for, among other things, accelerated vesting of 106,656 unvested restricted shares of the Company common stock. Stock based compensation expense for 2023 includes $349,832 related to the accelerated vesting of stock, which is recognized in separation expenses in the consolidated statements of operations. On March 2, 2022, the Company and the former chief executive officer and the former chief financial officer of Helix mutually agreed not to renew special advisor agreements. Per the terms of the agreements, options to purchase 366,166 shares of common stock continued to vest according to their original terms through March 2, 2023, and unvested stock options to purchase 732,332 shares of common stock were forfeited. The advisors were not required to perform services to the Company beyond the non-renewal date of March 2, 2022. As a result, management recorded $5,417,043 of stock compensation expenses during March 2022 related to the options that vested through the twelve months ending March 2, 2023, which is recognized in separation expenses in the consolidated statements of operations. Management believes that excluding stock-based compensation from Adjusted EBITDA assists management and investors in making meaningful comparisons between the Company’s operating performance and the operating performance of other companies that may use different forms of employee compensation or different valuation methodologies for their stock-based compensation. Investors should note that stock-based compensation is a key incentive offered to employees whose efforts contributed to the operating results in the periods presented and are expected to contribute to operating results in future periods. Investors should also note that such expenses will recur in the future.


•
Interest Expense. Interest expense is associated with the convertible notes entered into on September 1, 2021 in the amount of $24,000,000 (the “Notes”). The Notes are due on September 1, 2025, and accrue interest at an annual rate of 3.5%. Management excludes interest expense from Adjusted EBITDA (i) because it is not directly attributable to the performance of business operations and, accordingly, its exclusion assists management and investors in making period-to-period comparisons of operating performance and (ii) to assist management and investors in making comparisons to companies with different capital structures. Investors should note that interest expense associated with the Notes will recur in future periods.


•
Investment Income. Investment income is associated with the level of marketable debt securities and other interest-bearing accounts in which we invest. Interest and investment income can vary over time due to changes in interest rates and level of investments. Management excludes interest and investment income from Adjusted EBITDA (i) because these items are not directly attributable to the performance of business operations and, accordingly, their exclusion assists management and investors in making period-to-period comparisons of operating performance and (ii) to assist management and investors in making comparisons to companies with different capital structures. Investors should note that interest income will recur in future periods.


•
Other Items. The Company engages in other activities and transactions that can impact net income (loss). In the periods reported, these other items included (i) change in fair value of warrant liability relating to warrants assumed in the acquisition of Helix; (ii) gain on sale of investment relating to the sale of a minority equity interest;  (iii) gain on debt redemption, which relates to a gain on the early retirement of a portion of the convertible notes and (iv) litigation related expenses, which relate to certain litigation related to entities acquired in the acquisition of Helix. Management excludes these other items from Adjusted EBITDA because management believes these activities or transactions are not directly attributable to the performance of business operations and, accordingly, their exclusion assists management and investors in making period-to-period comparisons of operating performance. Investors should note that some of these other items may recur in future periods.


•
Severance expenses. Effective February 10, 2023, the Company’s Chief Executive Officer, President and Class II member of the Board of Directors resigned. In connection with the resignation, the Company entered into a separation agreement providing for, among other things, (i) salary continuation for twelve months and (ii) accelerated vesting of 106,656 unvested restricted shares of the Company common stock. Severance expenses for the year ended December 31, 2023 includes $250,000 related to the salary continuation. Managements excludes these other items from Adjusted EBITDA because management believes these costs are not recurring and not directly attributable to the performance of business operations and, accordingly, their exclusion assists management and investors in making period-to-period comparisons of operating performance. In addition, the Company records normal course of business severance expenses in the operating expense line item related to our employees’ activities.


•
Income tax expense. Management excludes the income tax expense from Adjusted EBITDA (i) because management believes that the income tax expense is not directly attributable to the underlying performance of business operations and, accordingly, its exclusion assists management and investors in making period-to-period comparisons of operating performance and (ii) to assist management and investors in making comparisons to companies with different tax attributes.

There are limitations to using non-GAAP financial measures because non-GAAP financial measures are not prepared in accordance with U.S. GAAP and may be different from non-GAAP financial measures provided by other companies.

The non-GAAP financial measures are limited in value because they exclude certain items that may have a material impact upon our reported financial results. In addition, they are subject to inherent limitations as they reflect the exercise of judgments by management about which items are adjusted to calculate our non-GAAP financial measures. We compensate for these limitations by analyzing current and future results on a U.S. GAAP basis as well as a non-GAAP basis and also by providing U.S. GAAP measures in our public disclosures.

Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with U.S. GAAP. We encourage investors and others to review our financial information in its entirety, not to rely on any single financial measure to evaluate our business and to view our non-GAAP financial measures in conjunction with the most directly comparable U.S. GAAP financial measures.

The following table reconciles the specific items excluded from U.S. GAAP metrics in the calculation of non-GAAP metrics for the periods shown below:
 
FORIAN INC.
RECONCILIATION OF US GAAP TO NON-GAAP FINANCIAL MEASURES
(UNAUDITED)

   
For the Three Months Ended
December 31,
    
For the Years Ended
December 31,
  
   
2023
    
2022
    
2023
    
2022
  
                         
Revenue
  
$
5,368,932
    
$
4,969,673
    
$
20,481,330
    
$
16,418,141
  
                                 
Net Income (loss) from continuing operations
  
$
(381,014
)
  
$
(1,900,105
)
  
$
1,733,430
     $
(19,191,990
 )
                                 
Depreciation and amortization
    
10,153
      
16,955
      
74,438
      
65,554
  
Stock based compensation expense
    
1,653,397
      
1,339,555
      
6,573,969
      
11,920,575
  
Change in fair value of warrant liability
    
104
      
(21,532
)
    
(3,984
)
    
(364,687
)
Interest and investment income
    
(661,188
)
    
(154,530
)
    
(2,327,974
)
    
(266,213
)
Interest expense
    
204,238
      
213,059
      
834,785
      
846,100
  
Gain on sale of investment
    
-
      
-
      
(5,805,858
)
    
-
  
Gain on debt redemption
    
-
      
-
      
(111,151
)
    
-
  
Severance expense
    
-
      
-
      
250,000
      
-
  
Litigation related expenses
    
281,505
      
77,184
      
1,032,985
      
258,872
  
Income tax expense
    
(73,547
)
    
3,980
      
85,740
      
23,980
  
                                 
Adjusted EBITDA - continuing operations
  
$
1,033,648
    
$
(425,434
)
  
$
2,336,380
    
$
(6,707,809
)


EX-101.SCH 3 fora-20240328.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 fora-20240328_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Ex Transition Period Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name EX-101.PRE 5 fora-20240328_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 image00001.jpg begin 644 image00001.jpg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end XML 8 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Document and Entity Information
Mar. 28, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Mar. 28, 2024
Entity File Number 001-40146
Entity Registrant Name FORIAN INC.
Entity Central Index Key 0001829280
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 85-3467693
Entity Address, Address Line One 41 University Drive
Entity Address, Address Line Two Suite 400
Entity Address, City or Town Newtown
Entity Address, State or Province PA
Entity Address, Postal Zip Code 18940
City Area Code 267
Local Phone Number 225-6263
Title of 12(b) Security Common Stock, $0.001 par value
Trading Symbol FORA
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1 html 1 24 1 false 0 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://moranalytics.co/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports ef20023970_8k.htm fora-20240328.xsd fora-20240328_lab.xml fora-20240328_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ef20023970_8k.htm": { "nsprefix": "fora", "nsuri": "http://moranalytics.co/20240328", "dts": { "inline": { "local": [ "ef20023970_8k.htm" ] }, "schema": { "local": [ "fora-20240328.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "labelLink": { "local": [ "fora-20240328_lab.xml" ] }, "presentationLink": { "local": [ "fora-20240328_pre.xml" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 30, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "report": { "R1": { "role": "http://moranalytics.co/role/DocumentAndEntityInformation", "longName": "000100 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c20240328to20240328", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20023970_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20240328to20240328", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20023970_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r7" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 16 0001140361-24-016154-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-24-016154-xbrl.zip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

M6 F>;!C$J MPZITDK/FPWKFA+&8)TG^\]D/N5I>\>*NBU45%RB2=\6,$G0EL?F58:F0FNG&T9U%8XQ0:U7*S;'HS3 M=3RLN(Y=8V37(Q^T!U86+)!EX]G2"+IP>1'?1'=A.59*L*=S2Z>W+Q)7)@+C!N6MCFU&L8MW0B*7# MK8I!4*H<,Z/&@"Y/'HZQK*SPU):S2'EG*UKKZ+%"B-3J?1V!NCY(*PNT[4BO M6EQS&8%3%OR_/YSQ_ABEGJYR!^O@TU$*0AH>@X7%D[6MQ67:/5^!3 M)!AUNT;I#Q-SVWF<,A F.2,P) M],IX[;6'@Z522ZCJ$VAO1D[9BFIHCN81JA',=0^,#6)Y-N7,-L"4JB.G--.: ME5)OER^P?HZ ZR_%@.?"!AQ36^-$\PP PS$MHM@F,0SF8@LK-B9U8-&,IJF9 M\T&#^M3^Q<&/2[J#CU$,B)5D%4$*+[LEF=@&%O80[9/PEH/L$\84"DA2+*4M M#=WO>M5[<3K?ZKUV^YQ^0VF?(S(HXFL5!S8 B4!6B&A0K1'<-FWL:KQ' GUM' M<:,H< G,E!1FK9!ICH7QN\=-[07&]KS-N91L66K4+@R_FC)OAB(YXJ&TC'DT M',7)2(@8$%)7(YA+6#-R<2-DT#48X?"B#Q">T!0=J!;J?KQ"FJZTH.*\8;G0 M*)_S2.1/U<#\H856Z:J>P%HH2.0DX1[UN*,R2\4F-CRPW3SJ$K'>8G$PX?2] M";MLL%.7X6B.QD\JRG8LQJZCP*=&E;VEF38S/2<\_KV*;<>)D@ECM?4S>$LD;)'FYMS&T[S*=T! MO(SP\R)4Q:2I:C,R>RI3S^XS:[DJ4;'2RMY[NSA66"9>1::^JLK2S#S*,NP% M.ZRQ#K1<^OS'L#"PL>MJNLZQIV+7M,"?Q)9.=*9:BKUG\;/.\M!>[:D=BZ'+ MF M+2NQ/D6G,PM^(+SROXF@#R53%IMC4F0F.MF>[+@,YQ'5# \=;KY%$MC63 M:MT0WE:%TH8B '#>I"6D/VI1J9@UM0/W[2,B8$9>9 (A>W,J$E8/VQ6R8!.K MJ60ES8J4;0@532/4]#Q%)XJ'35LFD-@&9S8V-.KHSMZ%RB]7;8%PZ27)B,>+ M18QK<%2N*NPI?+8A"[3[P6'*]LT@@CSFK$!UJR'BA*K5+'C4$0G=6 M /0E^-/+"/""LYK6U3#+,T=SL I-)/8 YH]D"YUL5VL9_,TW,]762 _EG]Z( MDPFRK3BTGYD)FTCPY2G,^"R+WK^_!D*I?7"81N=^)G^O,1 M0CP-N58EQ4-QMTPICE7-E7*CG(.C@Q6J*JZ+.<8.!@>7*-1CU#8H451*:ZPG M"W,7B'N=1O3;(?H?I:4H*AJ2&'TGP:C&MHO-;,]G*KFV2+U<-F6BJ9P#Z3F* M@@U=88I(\51F..-#$IC6WNA5NP\QV1-,U+4]E MFJZ8%M:(XZI$Y1KUP,ES-9VM$]@60K78WW0#YNLY21CY*YN"Z N)O_$4??[< MW1)IU_%B-ET+6MEGV)0;>B$3/B)'[AA1F;T +M8W4%E<;BZ922WP$P1V.CB8 MP@N[1;=Q=)?VA:LY%.D&)$&,>WZ8;S\5;RLEU=,<0I79Z&B6O;IDV(RG3&/ ?C5<]86AK2,.=#&DLY M9N^8"N1];:01_VYS)<^<" /P-$%#@PCZ?:.$BYK =1Y?HTX4<^7 MKG!V*I' O.PK&(O.[WSH6G!SR.\F7 @U8O[=%T>@ 7^3D(JE'$+E27CB)7&@ M(2,Q2[+<&K;,]]8/R,3W+C-L73:\OYE GYT44 ZK,<4$[G-<#O\;JB)"; Q3 M5^;P*63%(P)6":OME5?0T['I-,)0\_"HN?.ARJ[(W,E23W-XU ,XI $GLSD!72K&XR4E9$DE%Z/[#U>7'2W++/\2BB@SS):KWC"T]=P_5I[_?IU<:KASY&:9N"EZQV[.RRGE_(!TEJ*MHV@ M_CSFMFI]+\?"S*" BT9!*K= 7( .RR/\H('0QXERZD:@-$7!LS%T*]-_+F3[ MP$3:7J\UUQHJZPHS<:*+$%4/R#D4V;P^F"^]D+; 0$Y&H/P)V %BDTH,U@@! M"X2$(<@3*G-]@7!3&R+.22EL$&$4_#629YA(8GJC($#B6!Z462ZGG'(A1)"N MRJ[U%CH!*(=%GN],GR4C&D%;<>@G?6@%K'J>V3C"9N[[KI\BQVFIK3W1X,52 M7CBI[H7=ZY44;Z(4KZ8%])8]7EX#V! M#^$ZF#R6GTG&01,RF&4<#GQ)R:E_;@O5.(#X14="M*3@62JP\DY M G=@W:)DY/X;&A8VJV@R\(GK!UF;LA>2HB3K^%"R: 7ZZ<$#, 8PU2>GH0H$ M"8LZ3UY?FC":NX15^,#GYT-YV ^_EPPN,N+!SP>$ !-#-TEV!A"M]I>,8(Z2 M\@R0G3]'+O^E^W>H^YV6HOY(NG^JX>6F9+'4GZG^7*S460Y[YOK^9URIW=&V MS^H&F,6L5W=/P %;M#JX69#E MU2_9O&A+?G$$>.$X!:WLX3F$Y\90?G7JG/*&Q M/UP2ZEE//VT\/P8^8P'? WV7\-?>^E_(7]ON??OTVIBB: M[EC*O_B]XS355C\=-(Y% .2H318>2_:BYL'LI@WU76;#O$#$9=:F&)M'! M?-AOK5VX3\5OVQ$&+Y(9?BA)H"KXUR1?!W'="+I%8OT0]<2Z+J'RD*M3DI+L M;-0#L2+ Q.J F-PR$"VJBN\'(O&),<3R#PML;_?]S^.G/M'*^$R];.585GPX M3V]-C,Q_#2<4:QQ!42G;$) _:QQK-5SZ'W=1_Y&T\$TC%PLM_.O>I_.3FZ]7 MU8]JUX,3E?1)X8FU+-"B7R_**PHH;A?"N M;):,TGX4PRC8[++6KO( ?\+PCZ&TC#U:M "^F!#O&]H$>4]Q+-#"I:?RQV%V M[$3L&>LSG3]9SWCG73\GLJQF"V?C$=_%8ATT^Y&J]9V+)QO/AW%G$[B7L\I3 M[QS)Q]=.VNB,W9&8H6N0:#X/#M'_QK]$QVZP+3;?[(B?=@WZ+R;9%Z;E+LC= M<,DZ]L5*(SV;'/']?S[E2(0_Y;>M#]$G'O)8IKR.PH0',AL&3/68IR0>[R@= MYD?RMY:>ESJ;M[.Q^[F3@(3^J NY2>[2DB\F/X.O)"\Z,)(M/+QIQ?TU570> MM=V(C8_AMY\.@N/_ E!+ P04 " "K@GQ8R]"%';-9 2< @ %0 &5F M,C P,C,Y-S!?97@Y.2TQ+FAT;>U]ZW/;.++O]U-U_P=<3W;7J8(]?#^23.HZ MCC/K.ADG)_:\_(.^>=C&HR'/"E(D'%6P)WC/$JN&_>2K]^^]*.8$\,Z-H_U8]LP MK,;W3]/1719=#PJB^[Y-CHBA&5;SZT='Y7A_K@;\KI>&=Z1W':1QFOUR\%-? M_CD@>7$7\U\.^FE2'/79,(KOWI!_745#GI,+?DN^I4.6_.LMD9_GT=_\#=&U M4?&6%/Q'<<3BZ#IY0V+>ARORR6_(3YK\\_:@?+_XXLQ+&@\Y> _C$Q?+6\/H MIB;B("-)F@]8"-^J?C@@\FV_' !I"YY-1C[@@@QOB#7Z<6\,I,>"[]=9.D[" MH_F/FA,H'_F6#%EV'25'8CYO"!L7Z>125KZDO-9+LY##LY(TX=4\9X8_]TOY M:SW>YGOE4ROBWE;SZ*5Q>)_>!^_/?@RB7E00WS_6W_6RYM-_7OZV^\]9_;N+ M*/1D/KD_-['J#W/%NVAX3?(L^.4@&K)K+M9+/_YS= V?E.RBYJAG"$O(+L?Z M*R?M/D@1 %\!7/Z7CK!B0_QFS#!Y/6!*23^,X)O_A+!-"RR2? MHH0E0<1B\HWGX[C(6\?/TW^^9-GZ/I;AI$QJ+ M$?S&PXC]$67\W<_C]TL?_+*IUDHRN^X=FC##\N]K(>'J:QF-Q.0=3DA0#3L"RHPP,QC!UH;VMN+J?I1$^4 8YT % M.?/>'>$_> "$!A.<7;,HR0L">JNF47Q'1C$KER:(4V'8WPY806Y9#HM;9"S) M)^O'2JE+Y3L!2GDAS?O?V _RQ]UU&E)R.F 1W%P^[G00\?Z44&?E,&XX^=+O M@Q,A.:8<]S&IIG&>R'6AY!96?AS NN=]$/9WP(+#40[> MR;CBEHSWP>\0XQ>SZPF? [Y-@.L>8BL*3TZ -F/)1;5N2V]!K4MF#6 .-_#9 MO(YAPO40$\@#(//&O%5R&X7%0-RN_>/M 8G"7P[^UG6WKYNFXS/N6Z:G>P'C M!O-TTW/ZGL' >0YBEN?@D?8+.9.#ALB;\02*6<] 7 G)3>7/]M*B2(<'X$W> M9FPD_%WQW\E<895 $["X'GYY^X(Y5B0[*F]X0PQPB*<:M@B?/X1[KUHVIH5# M$*2&Y877Z$V*78\+X"BQUNL9Y,IT*MEI,L:* X2FC<)[(]8.YD:T)O-]3J!< M#3+.R6_PR2 G9_<4\;SN+:&TUB6]CY!U+'(_>7"!X<*%)Z%^-$O'_U\V)&/60MX$NJ;,686@SK_L]8>,P D.H];!= M-S]M' 8(@(4<"?QO(/\C_ZO%_]O@Q:\\B]+P*(6)'&T/ >5;R;W([^;>>#I@ MR37?!\#MR&:L_$/'^L?"K.+IZ=G9IT]O5V?J!>&M(_?8$*^:R4)6UQ[AB8/W MW\K S!8X8!G):@_Z80)MR1M\ =^^:![!.*MF\1 C/+J:KW:XC@L2U!5)_&>1 M)!D/UT 1FYJ.1WUSH1W33EYYQ#E&E")*VX92B_J.3QUWH;?=3EY!E.X>I5NE MO8K(6E2MMBA*2;R%/D<[U[]53L'.!$2KI$";H/XHGI6GZHY5%W(FEGZ;"N&Q.%1>F(9[) +J82\2JNH@)^@"DP? M"J,23\/8:36]K<=.=^6JG"=!.N3D, :7Y77ILX11/MWNHK#7TBJQM:_FR&9M M#IVZCD]]VU54;F'T#Y&C)G+ 6G=LASJ:WU+H=, D[Q@,U3&NMV]!&YJKJNW< M"0-9R3#_!=C#,_:S$E(%'?W.F@0[B^WIU/0\ZEM8U8@H192JBM)#D]I@T[N8 M=%/2W$?(*^4D*!6!UTU?5?^A^[%WC,+MF?NO/%4Q/HRBW4&T M(]I56D4%? 95$/IP#;.)<=1J>EC#_& -L[(>3*M$V;Y:)YLU0< "4747%08& M$31J@N:PQ:CI@''>,02J8V;OHII9V9V G3"5E0S^SUK1JAK'& +HK'6PLX ? MV T=K)C$PF8$:$< "I:]CODW%8U^1+M2KH)2$7G==%3U(KH?B\@F29U+*][_AF&/1&E'4'I MH678U#([F)O R&#OUV;,U_C!G?]GN7Z3L\S/+_O!Y[K M:Z;!_R#5==]F1^D:]H_%JU,36M-_IGQAQ[WV:HQU:_P M)H[/4KH]R&^+'C?/.44Z6O$<]IDQ_/,GWW']91)A]L5L7*1+7GR??O=?]2(= M4AT6#H_-2#'@Y*\QRP"[Y);EY)5];!'X:ARE"24L(5$29. ?9X46OROCA[=V+P: UP0 WO!)[8:?E812>-1S!#R%,A#"YOT*^1V!%/_;O M?==I?C=*E %/Z-NNYUM]S;=\W_![CN=[?<=W3=?1S#Z"9Y_!,Q=#?)>/1\OB MI'(L&*HQB9DSYD,5QF2-_]S,\[/UBZ.G'VA0^39@E_!H@>\-G MM9$R8/)L[GA]W=:]GF/UP>[RO- Q^LPTO+ZIV0S!M,]@.F7Y -@9_B7\KW$$ MS@^X33G86:$(\'_G):/E'+S,J(C@VZP@'WG ASW A:E38FB&"6,MX(LA>65Y MQV8-@;4R_'-]%/&]BK\_?/OZZ2N[YA_ ?/Q^ O],>#R( 9_2/QM,\AI _IJC MJRNE^[: [$M?,GG!"*X<]<2E(]8'B0)K'M^RNWQN]=X-,G W01N'7/B;\H?) M,\I1O"'6Z ?11C_F@-9+LY!G1]4U[2VI99TA;IT#W2*WL_ZH20N@["PU[]%V MG@I+4TC5:[+KWJ'I45+^??UT9)47;JO)]=(XA%%^&L> MC^,BG^?$U;EI?LZ/3?/I@N)3FD7@U80\!A4B--KJ9E%U#>CY1LI51I@<88S7M5+*L_/&YNN91]3(#DEHA>CYS>@SD M,W.LD+N]P-)U;NA],S1T3;>:T18YDZ?IJ'6G="N23<2/ /268WT+A["EL.K* M=*HD8#W&B@-(GL91>&_$VNHI\+J0827FG!-,5[<\!L/P-_AHD).S) 1\-[6G M4F')IZSR(_F]'54_/#J#:KS-?]L!H54MV@V#"D9= 4HH41IINJ47>HI7M4MSJX\Q]ABC6KBM6L5OUS#1LK5ZOI MX9Y]!:'?)GQW9_LIFA[E/=UZGO=Q"G+Z(,;M=7!O/J.*!*A3YUS<>@9S4] M/#3LP4/#E)!EK1)8^VJ);-;<\*GIFM2P747EEJ*6/R)G[Y%SZ%#7]:GOJ5I6 ML ?&>,=@J(Y9O7W;V3 ]56WG3AC(2L;G13.9&?M9":F"+GYG38+=!=]UJFL. M=3Q5#6V,OK>(\@C331GUADU]5Q=_NX?3#AC\B'FEW 2UHN_8+'DN-I)VMR1,(H'F^G40VZ6QABV7Z( M13O6[.ZY:1@#18!V!*"'VK&#M<<8_51J%16P]U5!Z++:8V7K)[H?_53(V5BA M]EA9=Z-50FQ?[9)->P>&KZ@84]0%0-#L/6C 8C=4K5?8 [.\8PA4Q\#&*F0, MV6_=BE;5.$;GO[/6P0YC\::EJ+C#6'R+*(\ W9QEK^S^0HS%[SW:U7$5U(K% M6X:J7D3W8_$8AMNS((#R5,4 ,7*FFE1%SNP$9V(E,H8U[_M))^&?X[S@(3G[ M<'[U\80<,IAR-B84!EO6>V M4=-TJ.EUL, 1PYZ(THZ@5/16TUSJ::K6 F'L<^\AKXX?JE;LT\2#W\2?^B>X MS'HQGWQRC\"-6-\\Y13I:\<3SF3'\\R???)]^]U_U(AU2'&=FP3^'8< MI0DE+"%1$F3@)')1/?[*.M;K#\7P\W$NGS'*(GB:>,A*V%\5*T_@^4#SM+[N M>[89.I9C]?V^X6J>K^F.%_8TGR'/[S//BT:345GFM7Q+]C)$Z,?N%!!PRRNQ MA75:)T;A:<,1_!#"9 @CHHQ,8D7WCXWY+SI:\XM1H@AZC,#KFR&S 36@)3S; MXYYG^+V>Z]N]T'-<1,\^HVE['PX+K\1< MMQ6U>VD)=2Z$.47F7@R@E! MT$\#,$'S-.;Q'0$1D(XS($W&R8"SN!@$HHZ;)2%(HSXG>1!Q<.ARTAOG()WR MG!*>#$0B1-@!\$W6B^*HN!,/#GD,[\M IB3IC;0/Y'/ 7P73&3Z7+XKA>?-P M>J&4>8J;9UN!X3(G[#G,TD,-E+>M@YYF MZ[YI&UY@F7:O!SQON88.?I[91YY?H$!&PPBX/A02NU1FD?2=MR\60LC M I65)F#8,GB3L'%9(DW;49;^R0/Q<@'!D _!_RS #X4+.?]K# B3R7F9]R?1 M$&Z_X;O$G>.9=N#Z@6U;GN6;EJ=Q%O9<\8L'UWJ(.\3=?=R=_1@!>U=,#B_C M\A6EM!G.9<_(=%PUQ^1_2QN"4Q MZY5/$#<)ER\$=,?I2"!$A%X& ,_*5!L-[O(HB !V&>_S3-A_\JN[ E+?"WW' M,6U3,W6KI_7]OA8RS^M[?=W7/(8*#(&T,&8_ J@,F$"#?NQ,(AXRCBBCC9_2 M3#!YD Z'XGJ1@G\DC;E1%H'_(MRCA%^GH%:$C@%5D^0L*-V: N[*..B@D?P= MOA"4P7[C6&_$.7>%&-_4=#/@NM\/0\LQF&?HMAGHW+9TR]!]C!8@8AY!#!N! M_?0C&I8P>#7-8 &3"V64CHN\ %4BP@#@Z\@!"_9,T@(>"RCZ$A1ICU=Q-*%S M &F"305>P$QK/!%N_HW!>\6MEOCM,?BM-WJPAACE4HY_,?,\'J2TR)=Q$:?I M]S7%)+@%CFAF\%MNM; MCA7V#2/L!WI?=QV4R"B1E]<=7&?I;3$0W,]_C$H?&!R 'J_3-R ;KZ7]8?]# M?*"O6$^T 4=&AJ!6U+^;816-$O'_9_').@E.2HI?#8#6&8]E&=0XAR$LWTDC M"J*$2R423S4GU(H\ L4?R C%#>C]=)R3WX\OCXE\4%3P87Y,+CF7M^:\],Z* MJ(CA"?_\R3,,[>T[,GR;A_J\;][F?QA??R34"0.K12RDL1 MD%SK0+Z)K$(0Q5%I+0%)IJ0 GEUYG%-^E3N7)*E#7K HSH_;9$4N)-+_C%E6 M\ R!YBT0!^ IEC.,6?"TR M2',1MPBF= EJNMR6=!&!#>N-J9'1\?"8G%T) WW6' =&:\H_T3IWG(/#5^0- M6 /'C6.X6+IGWP_BJ%]UU',E=0"XVY M*5*1=@Z^DW?C]P,NHC+C]\?D"NZKIRW) \J W0 ()'A%)EM00WRE*$;YFY]_ MYN$U/Q[R,&)'.<] 3![#7'X>#H.?1S_?6C=!-+H9RT- M5U4I>!A+#@*M>NGM[>UQ7ZZ=?$M)P#3+J[%7JDL&@*4;U7"2!,IU]RUHNB&\ M0BQ1D46]L7Q[#+]0,BJE<@[<2D#PLV*5E9B4[S]!C %//S*5^LWU?W:&KT4? M/QEM9-X8?'1ZE37\X=O73U_9-?^0%17 MRLK]9252BUXR><$(KASUQ*4CU@<0@248W[*[?,ZF>S?(0(.#\QURL=5 _C!Y M1CF*-\0:_2#:Z,><6=Y+LY!G1]4U[2VI;0A#W#IGHB_:<5!_U*3%P3PU%:D@ M.^FEXZ(*+:\ZPITKCXF>$$G3*(0/&0$A_1>XGOE8""6P-63R".X&=BD%.1N5 MM3^1N!UT"'QWE$5@1V1WLU$=&?QC\1V8E7F3I?(T'I=5Q*(X:%1$0QAQ55]1 M[K">%!JS4H8GPC"5=TR5#=PBWR6$O9#_H(\ "CPKU4]EWA<9FX0>96(-;K@6 ML:'9(B?Q4:,*:L3N0*E4CO69,(1/,(/FWH;<'3&B/$*8$ M1 7NE_$LX<& C9Z7I2?!7^-(!,1$:73!KP6]Q"^)H$D<_2V^(/."H'=Y)BA6 M7HL!LF+F+)XI_%I-$\ALX#/%Y>P\"4@F+LA93GBBNYH,!,0/QP'8$RDHW9C= M >.,0*T*+T5X"O.,*:L#9*ZT7-993A6Z,AT)AF:R/#;C Y[D0MM/^$M^.6;? M9=%:)-H*@*]5XP%IK MG@A^YW-0RF4%ZO&\,GFYN@*:E]GCQG@FUL%-!.;(0KOB(4ME):6^1 _%EN9 M]\C7*T(72O-3)B646(?+ E9&8I]\X]?T_2[^'UZTV8'>S#K M7XN]&0P8I78U^]6PXFI8^618M:O:D(T@;!,90N^7,74.<@Y0 -[T."LQ$[/; MG%;FIIQEY6@;[DG]KENZ[[ N4@O]A0UC#0IN@7W#YYBGZVX"EG/X*! MC,E,'VD$0+JCPNA9NK:U@L5K*XRD$[@>L!,YS\1ZB )YZ^.8I;,7^OQ6-1ZS5_..?^^X-K\)>$\ MW;N6CN-[KRZ$RIE.( =]'XLLS8^16!5I")3UPEE4[2X"^51O6\@K'@%NE]0Y MGF!OP7+W[L2M4=:D?,+D6M<\ -*N$$:"C#R!3Y+&()>S*/]>#F(,BYZ)M1#, M2(5ZN1,#*%=;*,H>OTN3L"J>3HHL+0T+\5&2BNI0EL'2\'+<%9]5?C&=K&QC MR$S:C=6-4RZ1O%%:03#%R0."*A]6%L!=W\G[R@7G8:TPF[-/^^ 0PR/*V8&] M_IT755E?*M O_>&\Y',PKTM?>AEY5YGDA!KYN"?*]H0NE>2EL[0M[\OS<5E* M42U((/@'%/=8#"DHQHV@@B@TC\1LQ!+"G,"_ORMWJ!6#%&ZOV(D+>LR*G+L' MYG0,/E8P[2HC!D OF:)) M90!O.1 8-J?D+AV3?"!?)H@/0 :Y!&Y2:91$4DQ)<_M./FK&TIYYJABKE+Q# ML"O%Q/@/81F6)!//NI/J('F07)^>3()*/E(0M\6$A6(0 F4PGE8T68)!P2-I M4-8"R+A2\Z"F&1ARVD"#^:2V(95C/XIK^DA]>G8Z">$U"6)J\CMFJ7MXG/-;R?#W!P4/G$B- M3(XLGWG\@V*X4F%0,1E9(SQG EU$0> MMI#Z2 K'6W@;!3X*^*@0CQ#JOR=@*'PQ'E: M_R;"FI+JYU5X3H3/"V#9-YM^]>+0X&;?&67_K^FR;/9EAN,>&89]Y!B.N>EW M77[Y_=OIV9NZM/$\">8S.NO+?&#H2\EU<5_;EV_G)!3F_.'T@ M#;C=(9U^N?AX=G%Y]I' 3Y=?/I]_/+F"7SZ:/;MP&ZVX)$S>5JM MR[H[?58DFZ!;X&6F8U"537I22ZBGMH!Z=! /=MMZSM#F1S*,PC#F"^A3"9;& MR$0X/ KG0G33P1JK=T5].2SG4-BT-1>5Q6QQ*-)L5:I9UE.8;+;O)/(^\OY3 M>=_H-N_OJ"_UPGD\K5WA=O&)R#QX?_C[QI53"=7CQ.JQ7 MB"PSCC9V&L=S1,C!^]-QELDJ'UDV+F%O86C19ZW MJ"\Y;^2IB[>3@PN>1Q:':I9!?<]1R@'?_M% B$_$IXKX-*CKV]2UU,J8;!*? MVS=-5+,_?I.UG3*7/2WAWHGMH;0 6_-I16L5(CN0%*#&#=^AMJ?J\6&*Z&OD MZ?;PM.Y2$WC:\MQN\32ZWP_V+0Y@F(4H-0XXN-Z@!T4#U-6Z *-UO^U3_CIM M?-LN.,>FKJCT0><8X:,P?'1QEBW5#&]OX(.^Z]:3&DLJS9B4!Q+)OZMJ6H0%%$Z2)+MX>EC[K%RNC8/I17 M%ET&1"O,LO(%_5DTR+>M/W7#H:Z^/\DDA _"9VWP,:AA&V!^HC^[&@]TPY_E M(Q:%LN%4DF,:%@WZ1W6LYKK4,%75L8HH4F3I]K"T9]K45;9"L#6JK46>ZI>J MLQ*ZJ6AG[R3MJMO4UE0M9$(W%>&C,'PLTZ"FB4[J:ASP+$V^N-N$6CI\=IOE M\M3KCA3\-EL:K(EQG]KO0$$Y]:(I[&$:3+U6( @AA-"2P)/IF]3QE%7\RC9? MZ9CS?I46XH"#&?6/3CQZ(=L51[9+#=>EOFZK*H_0BT?\J(L?PP'L.%@]_>Q) M/B_[O,V^-IM,A^TBX_),$+^4BB]+ERE/U5UT7$+.1,[$#.L&>^!]S43\M2A/ M+!(=ID;B@!O>- M\Z4QM8@V]VXJ'6S#I+ZU/YD1A _"9WWP\1WJN/L3[^EL??"+]/E%FLS5"&&) M,-8W*ES?B"7"""&$T LU/]5,EWJNJG&HSM4(BP4R-(L2P_3@']M^?7^.UD:, M \-^>0VQ6@[^RK146[ZM-*\Y$0+3(F$Z%LTTGR@&UR]$5#ZH90.DW&2)M$<] MSZ..KM:1X!L%X>X#'2A&4(QT2HQ8#C5 E.B.JH=D;%^,M*Z2''.FZN5,VUY_ MBYR&G(9Y<[+^;9AB/MY>>W7#"%F%L9J98:M:-:"(GD:6;@]+F]1U'.IZ MJAX@AK)^?>=:;:GJ M[,\>QXLY:?1:=N:U.-0S/>H8^U,7BO!!^*P-/AXU;7#\L77V,R>YA3Y*N#,2 M=T;N.O6%G(FU'SB,\I^,*RC%BY]A'8?D8I,8'M9[ )$Z( 4:"( MBE4MWOE%G@VXZSBGTM$8E4,N.TF5:)HF_BH:5U$D]H@LW2*6UJB/I^.VRGM\ M81U0FL@9B@,!DK3@D]9/\G1X61+$>P6)\GS,@,SPEKS(R>$KIY9])$K(*(N2 M(!JQ&.XC QZ'I'='&,EXS H>PA.SXNXUI@V5-+:5,:XW4.QH4<_5J.YAL3#B M!_'S=/S85-<ALY'#E<*0Y'U__EKC\Z_.@,[+,S8!K4U3SJ:>@,(,81X]W$N$D]TZ:. MCT&]QJ3;M=$:RYC5*V-6QJE01-$AIR&G;<-3'49A&'.%2ME?M!'Z-!T.HV+( MQ?'%+ E)695VS9/@94XI[@1=PSQP)Z@Z:X'[H1$%B +E-*UBZO2R2(/O@S0& M5SS_%^%_C:/B3HVV(JV2$FT2!>W!NZ*J#3D3.5,%=?/,%*2J>Y2_9O6Y0U(I MB0!F)D@QYN25=JQI^EMB3[8C7PY8!@]@XV*09C#U\"W1Y/9E^+IP"]-QD1?P M@SANE\D=3!]YP(<]GA%3I\30#%/<-T\!]'053@7MH56;0#1?ZJEN\?6BYU/)M:NJ6J MA'I.9?[Z";6C5KV(5D1K ZVV1UW?H+JF:D"@56A5(@S1[CW.^8**.%7"%+@1 MLEU2M]T;(0V'ZJZ/FYT1XXCQKF)<-ZAEP%\7,=Z8]*[#/9:RUE&S+;RH;U#' M6EI(0[5EY*Q0^$F3?TB8CL4Q/0^-?RKYUB\17FUQ^9[DM#Z!/AL4F."O>IY' M'?TE=3M;]5;/F.69O)[U6 ^?/OZZ2N[YA\RSKZ?P#\3J@0Q9YF;?72Z:"7OF3R@A%<.>J)2T>L#W+A#6'Q+;O+Y^RD=X,,%BX?L)"+ ME9,_3)Y1CD(2FVA \,F":-J4DZMKVELRX(+;2UNR-IHJ_EZ89:P_:M("*#M+ MS?NT76#1!6#$\>QYEMI]2U->N*TFTP-;#4;UZJS*D$Z_7'P\ MN[@\^TC@I\LOG\\_GES!+Y=7\)_?SBZN+LF73^3+U[-O)U?G<,/3AKV6$1[^ M?G'R^\=S&-7KY6]_$K8D1(F -^ ^ ('PRX%V('^O!(3\O>1,^6/S)4^9SGTA M-<^U32P!OS?)#(S"8U@LL*[ -S^1!GQEV+PPY=]RP*:3D3 X6R*%R MGMMH%[4XQKQ1TV:;@9F5Z;!$)9#D:I!Q3GZ# M.P8Y.0,/-ERDM;RUR/LA=(+V0NE5UL,Q,UR^ZZC M%+-LN]O&3KN4.K@.N ZX#K@.:UR'[18PV49[VHC+DJ-=[=WTK; MZ7((E?;JVM1T/.J;:AGFN-4=\8GXE&5*U'=\ZKAJQ640GXA/Q*?< *51R].I M:6*O& 0H E0]@.H.M72/ZI:RF\=5:4:SIJ,8A;./YR[@N0NJ415/!$'.5).J MR)G(F6I2%3D3.5--JF)^:YWYK=,TK\[*/?LQXDG.36U;U=H"174DHX>P[KMJ!HW;BIA4X>>:6!6II+K4]5<-^"!^$ MC\+PL:BF@:_I^'L#G^V[H8KYFIIX(0*AZMA.R-++T M$UG:I+[E4\WHF$V"&;3E2_XK3WC&8NG7L' 8)5%>9*R(;M0H*L18OU)&XNYR M:-2P-*J[JBI;S**UB/*(K!ED>:Y#70T3 6U 4CN1TPJD/#./9E+'-*GN8QX: M\8/X>4[K/,_UJ6>K&AG$3-KZ,VE\Q(2/F2:$5ZU E' V6V7WMLFXW:P%>Z2H MY%#4\4,N1RY7E_K=],/CV8U,:,O1>,#2U=)=JEJHQ@-8X M*@N<+;$4AF918I@>_&/;KY<=6:Z4C_.1CS(>1*67(Y-KPQ3H\;>\H(2W\Q): MM\F$7'&>V(YH$6XGLZZ6W' M3%H0#;E*"Q;#=^L3(-:0]GV!R&RA,.R F%-6@%'#TZAI*KN56V7K Z&$4&I" MR3,\ZBG;@0^AA%!J"90,AVJN0TU+U30Y8@FQU!(LF38U78WZ]C[HI=T?B_'@ MYE?<4X!["F;QKG*V$'?*(%WCJLQ';7BZ>1?1EQL24RN M29SF.?F4I4-R"O=%R5A(U01JCN' MJDX]VZ>ZH6P)'((5P8I@+<%J4]NWJ:9W*NF&8$6P=A&LND=]VZ">KFSKNC:A M%?.&&+7#J)T:43OD:N1JY&KD:N1JY&KD:N3J?<@;MB!%6 QX1LZ3(!UR2692W^N@=D/H M('0V#AW'HHZG[!80S$BMVWT]3P"Y/"]D \4HN8$?A_ J^%$DI)0PB5ME][;) MN-VL!>LX.M4]53>H8(P6>7V-QPW8%KAKJE:,*V)8*FT]JFPB[L .-*AIN-1W M576CD*61I9_<^]*AAJ[J<5"M\5]6:WZOF)?S*XL2DB8D9[%,SDT='24\G!5I MVB;;\&534M&"?-F,NGU<\\MHTXISZQ!]B#Y$WT;2"]M FSKT5L'\W@*:GF>H MV=33X*^M:M@0%1TJ.E1T[5QMY5QIQ9SD22JP.D=-"=>X5=*H37)FP_6E I.& MLB>T[D$A*0*GI<#13:K9JAX;J"QP% **PL!0!PC/,U$./=.BKF=W$!W/(PA" M!B'S&&0LA^I:6VM3=@4951.KZA^$,,VVAKQ7D(R'?#@2AQPH819OX.QV)2WJ M%>>YDU:R"L3/MM& MN-AMLT?U8JH1]0CZA7C'94/:%8(Y?N"ZHZB^'F&KZ[K M5%?W/&A% (YJO4L" -4ZJO5=ATX4BW]&;@]#'YH.]7U5^TJHFH1 Q.PO8EQJZ1;5/55[ M@*$20)9^JA(P=)L:F(K>XS/TL%'F&N;1DD@-GGB#*$ 4( H0!8@"1 &B %& M*,#LT/O#SVF>OZX30_TL'<*#DB)*QE%R3=(1SYBHELU)C_?3C-MBYT[#H^C"!'D.\2Y(?B8#Y5C:MU@_Q%E-J- [YS ;%>@; 2 MQW>AE^\6)KK1!C4V=2T4"^T*UG5,5JAK/'346'AN!3&:$'L3S]E8T&9M*7JY MF5.<)U2P'^K&<5KFQ\W*GI\T^:>2/P]-1TWG[+FS69?'Y>E4TU4]Q>]9N\YW MYE@A3!&F&X*I3GU-H[JF:@D" A6!BD 590^N:5)+V9.>6]6\";&%V)JOO_!! M$_J=0M<6M"!N$,;M,"T0+[@=!E& *$ 4( H0!8@"1 &B %& &X3O.WTB^5@F M'<,HK_*./&RD'94(C;9*8K1)+&PVRJ)JFVI%529R>2NY_%"GEN=2L[7=,SN0 M.T/HM!,ZOD4M0]6M.(@;Q(VBN'&HIQO4UTV$SK))[Z"PM#5[@JN:T^OJ[-2< MQ5Q4EJKL F(\22GY]I)X4B=]2HS0MHCRB*@9_]7QJ:&L%=[&;;$(4@3IFHM! M=6J;.O4LOWLP1?V'T-HAM$QPI$U58[==2'EN=\/E\SSB:9W(2L6 M<4*@(E#W3/DIXA.W)X%<%VW8SO4T91-N76EBS0*!10*+1$*/C5=DQJHW!''B.,6X_C0H:X+ M5KJGZNFE+53N"D11+-4J"\K/;[F AIA3',+X+GA1]WLN(RAJ=-6W-A'HW:3@ MA &3,!WW8O[4KO@/<A(@MG^Z) M:$6T;OG\"Y/:-IA)[>GHO@I'ADU]5Q=_7[_KS3O* E"=!UF7>DFW8Q]2._<=*;//2*$0\G8B^LC5 MR-7(UHS>PNT-@[V4$R8AG)!^PC.\DNJ@T[%7&=GL MK(CN04Y#3D-.0TY#3D-.ZSZG[=[&W<4>PT?-WP\LCX+=I-'1]=TFP-'UQ8 . MCU=/O 8F G &D@X!$0"(@U0 DX%'5]J&*>)<(%X1+4W\Y6DOQ MLBO]M7O'>(&S+V9J:!8EANG!/[;]>EN';*SL4W]<^]D9:PVQK4Q!E>7GBO.: MVP0'TZHZ\."VVP>B@NNGY'X:0AL W^XC]"@^4'QT2'P<[J?\Z$I,! 44"JAN M"RCMV%"V"S/:-R@^4'PH+3[ OC%4S:1VT+[!1K!/W.-)CH +=E8"W_K65'5? MZ:JUTT/CWQ-Q_6SZ;#9&U:E.DM@Y#N'9(7B"C:0K:R-AIU<4 "@ -JV?3=3/ M"$^$IYKP!/WX;V_5P:F X_: 51$]@YR&G(:B$B@(4!!L55^KV[L)]37"%&&J?H^D-NEK1;H?[>*@W^>1]>'&2.$. MBY:?3-@VB><%VYHQNKR:U%X/Z;#7TDLPM6MS#$4!BH(VB(+6]75J88(*A0T* M&Q0V+>PAA78'B@(4!=BOJJ5VQ_9#3;CC#7>\X=Y*Y#3D-.0TY#3D-.2TEG': M>DW&(AUU.C7Y!Q<,PL,C!C-GU[S,2N8D'1=YP1(Y,]6.;L'@@&I"I76^NVE0 MR_:I9WI[XL!C, _QVFZ\:IY'31OQBGA%O+8"KZ9&/;LU&R00KXC7/<>K3C5? MV68KV\'K[C=B8P0-(V@8JT5.VV-.6W6@.^"\7=#PF9SX4BHB9R)G(F>JQYF8 MWUI[?@MWX*%'WT&/'C-D=O'_7FSYCEISR>]5@/GS[^NDK^-P?,LZ^G\ _ M$X(%,6>9),)@XNP7Z:@F7W6E)D3UTNF@E[YD\H(17#GJB4M'K ]RX UA\2V[ MR^?"$^\&&:QI/F A%XLJ?Y@\HQR%7 >BB;6HUTK3IOQ?7=/>DH&,-)2=F^I@ M186*A'9Q>?:1P$^77SZ??SRY@E\NK^ _OYU=7%V2+Y_(Z_7YS\_O$!#B)6R(P#\(@ 'RRX%V('^O!(K\ MO617^6/S)4^9SGVA-L_*38 #OOL_%N) M%^=E4IJ18L#)?T!\YN0L"7E(/O* #WL\(Z#IE5+S:VS#N:,2E:XB8PD=AE$8 MQOR%2#"V@P1B:(;9579'5MHF*P$G&5WEI.WTDMA8_O,YRSFU?\FG;U]^(U^^ MGGT[N3J_^)6?Z&G,^2J%X8C M6I./?GSTZQ%K/C5=DQJVLL:$AI3>W6_DD&' M!;J_4ORP:#O7_/OH%.U2F.TJ?D!=TZ26J:DJQ#!\@$A1 BF'ND]U'UQ^OX-8 MZ:3:WZ%N/PG_'.?%$)Z4DR(E&0?-'D0Q)\F]0Q3A8W$Q8/F C++T)A(E0+T[ M5V; F 4L*"(;J(B@M<=+3867I('Q7WAN"]\U_O"D3.1,]7DS(Z[ MK8:]HFK[R$>@SB*I;@A+0L*&*0:(\'S.@'Y V+S#E MB?;QYD2+34U3K8V&Z$4B2A EZ$1N2P$'03:6N46 )<\+X4B>IHFC"<9$6 M?#78EW+8VZ#KJ2^^%*BKTSXZ0@1Z*4 M)N \S,O"VIR!7JMO4&5S#5K2VQ0SNRL<-#V?&EX'$Y=;J!I$T"'HGL-=1]U# MFS*VP(Y=5[Y V\/3OO.RAV3.@?%EC2RZL.@&3*OWJ>05V+4% 3 M"H9C4\M2-;BK !#0O2ZI]2N+9)51[3U'R0TO=[6@[8ZV^^8$E$T]#?ZJ>X@0 MNLP(N\[!#EWFU9:Y92YSK<1EF57&0SX<[6RGCM+R0F6AL&GG6+21M%5M9--! MG8I 4!((JJK UN@Y-?W8RR(-OA_UF&BH$*3#$4_R,F7,?XB?.9K5:%9O;CL> MM5V3^HZOJ&S!DF-$BAI( 2/4-S2 BZHY&O1$7Z2&3P8$W-$^BS(QJ;$, M*]^R+&-)0>*(]:(X*N[0)$>3?%H]17U/U=WLZ)DB#+8% \=2^)0/!8#0<6=W MY=:#4RW;Z!LH.D/DLEM3K60CKDBOP&U:]XH9ARKV<7N)]=_FM=AQ7T)$ :) M@;5 =W6FUEA4%^>B>R^/;D1Q,5KD:)%/+'+7 ==4PS)*!,*^ \&UJ875 \LG MW7'7=/4 ,-R0L:"H_%%,NRII6"MC2+\LF41UPZ&&M3^Y)$0*(N4Y2#D$J/@. MU91MDJ%VN?U>^<1?,SYB45@73N$66_0#&OL*+9U:EJI21 %1@4#8"R 8U/0Z MUBP-/=AF&KZN9/:IQ&[VUGA$UK56Q47.TQ V1:HU0[: MU2W4M@BZ?0&=J5/3P19KF/-]W!:0QP5ASA>=@'M.@.N#,ZRJYE:DD IY5TG> MM2V/.F9;MY:C _M(-+?/LPRT5L9O>#+>D=9"8WJK\F*'QK3C4M?$9"QZL BZ M[57X^Y9)74-5#=Z%?"P9L3",DNNC\F90P*,?NU3K7V1>ME%TM1L)LY J:LN6 M- MYUAPPR=,X OOHNG>H42+^_UIQ.?.B*:Q+YFB:)OZJ*G.>PIG;WD^$J-E3 MU*C:5GF=:$''NUSK"UZ0@.4#<0#O312"!]Z[(X?C7)XW_[K9DRHHHINR_4.NMF=S!2KYK)/ M#(+*!EAF LC3?*45 +?MV@A 5V5/795#VP=YIVI5Z[,M3V=ZJZR,90U U-=>V<)%9]7DH_UPRVO'U:F M5;\BF@XY#3EM+]/;[DJ.9/GY+1>K+R81AZ(EV,GEO\FGSU_^N"2?OGWYC9Q? M_._9Y=7YQ:_DY/3J_'_/K\[/+O&DI7:F\/",&542U8@"1,$^H: +.XQ7/K+P M!)Q/F>PE12I"M",8_IWLP\7_&D>C(;P"-QUWRAQ^63A%G#>C;.F6 K$1Q,%^ MX,!RJ>.J&NQ7 <==UI7UJ]?QUDP$-VJT[YXPG=>B)Y>).> D1TF.UN;06EI M?F1GFZ,MBVJNV""M:J,0M5,="#P$WK. 9]O4TWUJ6MB8H!WFPPYMA$L6*V8? M*"V+5!8X&]X";>A4LTWJ*KLC!).IR+\/M/T"]O7 <7;:&D!2)F*LJ+.;I0'G M84[Z63HD>:76HN2&Y\7.(LEH;#0V+6KI);;]3^WVQG1?"9L,)'9?Z MFK(Q9=R@V^8&8KZ+C4< MMWM0Z::1H'J[L"5& $80T!7:O2ND;!03 P>(%N70R_$)>+RT*&6HU/-:E4:L9.!D+6V]WIHFC.FBC\J MIM# 2OD.51HKTV%"$5V)G(:+ UDCIK@0W" M$ 6( N7T[2[W=+$[L74K)VD"RU3 QR-V)_5==8.$;?$Y5U:/W_BHT>$K2(=#T)-YD0;? ML2I:28-9&0/Y9?+)I):MB68@BHHHM5,<"+N]A1WZI=WP2T\GAKAI![4B D%)('0L(J.$)RHJN0W-HL0P M/?C'ME\KUPFD"N0*-Y4/1W%ZQSE,JA@,TE@,DQ3L!^C1F!6U2LV++ K$;]*= M)>,DVE%D]R7T5ED$K3BO+NR V,)$UQ7X\W5J.%6[WK[>>4U#\0>..$R"_]9%3L8 M2Y&W:K5N9P> 20W+A;\=W " ?=$1*6OUUFRJ6P9U+6R,WE:';$?]*-8N!W9A MOJG86:+S1C%R)G*FFIR)[MIT_YAH82(SG?RO<00S%LU+*.EQ>%PBBZSZ9,2S M* W1E4,#=7-G85+7M\$\15<.D8)(>0@IXO1+TZ.6K^HN3F4V=:_1^UI2GK2K M%H%;R>!OED=VD:O?<*/ ]63EU5FCC1_BA(A 1.PK(I1P055\U=7)G++K/05*M-@6B1,QZ(7S1.EV(M,Y%=;7/H-U/,]E6KK\2L< MJED&];V.;>]\"%F[]]!1-J!L:(%L:&%T;L.R8?ZP_90,*X]8%,*M&>A,0!K/"]S1^'0[ MN!OQFB1UOQ:R&T)G9W65%M4 MB]I>8P4RHJ[EJ-,]:EG6WD!NSDJH?X++XCCAR2?W2-B8R<'[=[WI,V8I)[]7 M#>;#MZ^?OK)K_B'C[/L)_#.A31!SELGY#B:*'@R.FE+5E3I)6KUT.NBE+YF\ M8 17CGKBTA'K [[?$!;?LKM\SC1Y-\A@^?(!"[E8/_G#Y!GE*,J$MS;Z,5T6 M39M6%E;7M+=D4,7%144>J==*DW\6+F/]49,60-E9:MZG[5(C:J7@?9,?%T7S M+]+DZ->3DZ_D4]ELDL7D-\Y$0#]?/I8G\\=JAJ#IK)R3F'GY>4**0923$0PZ M%X>IP 0X);><#-@-A\OI313RD 2 /A:)\[2K.0^KF<*]@R@8B&^$O!\EG+"\ M[KX)!&DD,^!%K(#'YN*@,]+C/!%O';&L[-C)@@"X!+[&ITPG#GLAOQ]?'A/Q MSF-R->#3$4Q?4HUE.MH!SS@\$N8%["*VQ>7P/A@(GP2*:&GN4OFXH"Y1!+;B M&8D*/LS)X3]_\@Q#>WL2_CG.Q9DR9Q_.KSZ>R*OZV]?UO/-!.HY#>#RYB?@M MW ;SRYMIGB*E\MEBTO 9@YG&,(8$: ($AD'!&'@! PO2(2=@A\4)[C5MPS 2S-;@BK0O;SU-AR#_[P0)=/=M+JI.)6L*6@KW9S3. M1FD. X+[>^,<.!F6(>1!E,/CCH;L.[ 1%]<7C- M166K')>XPG^,> )#$E"1;,!!(XYA[>&S45K P 4#L^"O,;Q']L87+ !T!1XM MOW5,OLKZ6)#Y1V6EK#BS%V 3Y?+N/IFGT8#'HWGJ1&(9HOY=DT!%!D/+!5LM MHL\47C"(<5SD)7Z'[*["KV#]VV1*ASR->7PG5F;TR("G_'Y,SJ=K)L6.>#ZL M\+U)14)^"/P&8B* '/%,GN2E: 'D7V<,4,L >6 EB((KP$$N(56N?WV"5#EA MH8_$'=5R\,=8Y)A\F25HQH/T.@%6+>DR)<.]U6#BC4(BP;?B:!@5Y1D(0,& MCL MN0"@I1#KCX5R@(D+K*=910(>92 G6'R71WG-NC4 Q2*"F29AE,,R F^()XA7 MUI=O!U(P3E>CL<* :$'HHGZY$$9%%/Z "AY:30:*[ =.JE.2">/[< H/Q3D--"UTLMRB2:$S'QR9K5 M*E,0^-[72U)-5PZFP6>$7(\7M\+ :4B5AH$A[TPBWA"ITMH*HWZ_E!,!&T7" M>,B+;!P4I9TU_93##X$4@I75( _"@R63*F9* '&9%4!Q@.+L$ZKG R,+@R6' MN0HY6'[_9ZF ZCO%TN4S)_ U!>\Q^7=Z"Y0'(V8!DPL](0RN)"SM(@:644_J MM4HBS9","9Y(DPGE)1=4#"+HU[P9%F6.E'2Z'%,")+RVAPB[%;)+TGM*?L'Y MTZG>LVUG%$0)S:E6G%$.YQ-6J.S!$:RIJ.[A8@&$QA+V;SHK5Z6]+'DT(J=,6J[*:@QJ*%K^'H6_'/SM\GA5J)NL%FM'W',^>A#L^7G[]]#G*BROQ[(,50SY+LQJE8W]_$><\ M]H,%X9-RAHO2+=68JEQF?2DG&7AS]D7 MLW&1+GGQ/?J]*#ZWB%;BTM(HV]-K&*M7B.>](5*%!/"6CQQ,GJ 24T(@G8#" M+J*_*QWQ[F?QK8?',ON0__-?T_^1>W_$&UCC#:67):P8H6,F'GU]51X1*\V, M=*)8[_EEH*=88LQYB7MDAI59>VWNWL HNG"VMSEIYBJZIPD-)Q#L^47Y#QE@G?+&*C M8W(B8S8PW?B.+B>WC,+)A5.P@GU$-6;JQTW$WV:-\C?2:Y1%!Y>.J$1W70NH9_24?R@N\)QC_ MWTG\_PDF5!#XCFVZ7M]U^U;@6IYC]IFO6]PS M/3&)I0ZS>A%AD2"[,L:&DU M+:U+<;#]T0?I*Y\V(Z!GI8P[7LW66B1>RT>7;OA,*!PO\/2H:[CL,?DMV7*L#1PRL@0K\(=\T^<&>)"$V>QPEPT]2?KT$J;S0>, M%^K5B:FU XMJDLB8-9T6T6!MUI08$=BZ5:A06UGW6:*14JGO%6<1I$DB M0ERPM&6$KF&=':_ J4EE(-=IRUSD&2O/XO[4)Q.N[?"*KC()4TY##ARH6(W@ M;!*!^\1[V5C02-YX2B?IHED!*E!V";JQ?-@"66S M)?G 7,3?!=6;UKIDO"\)2,T,GFU(;C-FEK:.!*(Q5CH/M5N6+6" M$% M0*UP\2OZY.6'@H09KYW*M!;EP#39#1 _KSFO7NP>OTNK51-*69)>;"L%UEGH M//=G.0<R"$4L<\[E/@@?!)/A<_D>I"/F]3L9-- MITYZG/NAQ9GNLKX5VIK?=TS=MAGS[;ZA]73T^]'O5\3O/Z_J%B=^_HI)EC$4AG"P4ZQ/SV/['C&*?)&2B>7(OU. B$- HO*DJ)2;^?5VR45>QS1?1 M+/?KZ=3*%'XNA480= S+%!^/C-LVS8"S37543O*IJFWRQ*H-;7;?%HF9;B*TAR[[S$C$A[\';!,"C(JJJ JH- M 97@..IQ)KU3(67'5:ARLOVAE&1" M6Z8R+>FH.ZEF?IS.R9O&=ZAM?O^5K/ MUWMH)*"1L%DC88G.^R*5\WFU7^1QD^'1T2Q^3;,:#US@:U:IT=(V8"(-.#48 MBHPE.0L:(6JA[R/XL)[9VW,T41%9?$%G(O-CLNL\.#U5U M+H[_+\I#B**RW#MXGO$AA="P.H#MAZ 2^ MY06F:5FNX8>]P&",FWU',T*GCRH> ^%*6 ('[R_%;C,I:FIIO&J\X'[-SB)) MT98RGG75[( QL="'9+&(4525%54V6F@'F5VO4^D3%W=3E3_W%GL=L9(J6TSN MP&I8-'=1#R7LK(\\*)?/+/,/DQ*&29G1*\,N4QMS-0H+J-=4Z_ES]?HZ9C]5 ML \$C.8LA"#-BZDQ,-UW7O>U:)-Y,+4%%MJ'L^9!8Q=RDTO+"AF1MH%;12'% M.,MG)Y??Y]S*YIN:(G6.2&X7$HO?9".Q!^,+/' M?^6L\@/;S!8^<)44]).KS/AU[6[(\P5\38KCX(CU%4+E5) MS#* V$C2W=5R:1+;:K0!FG0L843L:I4G5M*8,94Y?/EV,JDCQ MOH5U)\>5CWM_BAT_LCO.@LY)+"_OS7@_EO?)]DD\"Z+2"OMS'%Z7=O9L9QK6 M2\=%7>D[R4"R6H[*[>%5VS4YA0?H=TS^:!2JUOV5^&Q_)?%ZV]92;O?DA E+NP_APGI."8?7_ILM]K%%1:NG7#);ZP ]YLMZ"FC"V; MFM7[0BH=4C<2FW:5*F^K5$630>KTG^RH6/8U>S-O.&Y!P-9=D'?,&Y^^?#L_ MN2#G%Z-SXRZ/ MAEIF!&85'+*LA\/M,#7,[D:?&:=9\3/'_2 ML1#N&SX'8.$KMW20WWA M\KN4.K@.N ZX#K@.:UR']9[2O=0RJ1((MK'E@[JK:VNS7+Z5G='Q#&\53A-^ MSJKNP1'#SR.+34W'H[ZIEF&.IWTC/A&?@BP6]1V?.JY:<1G$)^(3\?DO&=.B MEJ=3T]00H A0!*AR -4=:ND>U2U];P"ZHV*%AK._-=FAM(!X7 ILE$H/@O11 M).XVK+4"%;>LI9#3D-.0TY#3D-.0T[K/:9@?>E)^Z(+7/;:K_I,/G&2/223T ML3OF8Q^:GDXUW>J>A[U^6KU&_"/^NX9_G?J:1G7-1@F $F#G2X<28/M1=NJ: M)K4P"X;X? H^7R%R#G6?ZCXH4%^[WX:2D.[AZ37FJQ2%,D;<,+:+G(:ON#OUJ.;RZ M1G4;MS,@=A [SREF]NT.)ED0.XB=36/'M:AE>H@=Q YBYZG8<6QJVQTL[U'& MFU3,9;P4IT2*@U!X>0"4/(M%N(_5L58[\1J5%C,JRY*=U ,XMDE-WU549BBB M5)&EV\32INF#&E35_4*61I9^JEE';=<4#4:0I9&EN\'2NDY]0P.^[IB8Q@37 M\C4_';!$'@E(^BS*! W&\K3*6Y9E3)YPR7I1'!5WF.S"P,FVDUW[$S5!X"!P MU@:<0T.G=A>[4N)^(D1G^]$)7J/70POAN??YP'-Q M$A#/"UD^&B4W\.,07@4_BIXGF W$H-S#$LEQ=*I[JA;?J"IV$#)[#!G=ML ! M5G4_/4(&(:,<9 QJ&B[U754=4P0-@D8]T#@.-715]^.H"AE,QZ[@+.ZR6!0C M8.NF;8LB8(9F40/W>B!X$#S/ (]N4LU6M200P8/@41@\GFE1UU.U]A#!@^!1 M&3R60W5-U9 G;C-159& M5D961E;>=C;!IIX&?VU58V^JYA,0-/L+FH[)?TR-/>[PA+Q7D(R'?#C")IP8 M:D&9@Q%*A W"!F&#L.DB; YU7:>ZK7>PS/_=%J>Y]QN^0P"09$ MPDZ>&)UJM7!0Q*Y%5D961E9&5MYVD:ZM44W94BED:&3H_9;-F 1;OM2?HR*Z M+H\3R'C,"A[6SDB.L0^,?6Q9D7HZM34LV$?P('B>?J262_4NM@%$["!V-HT= MG6JF07W<*X;P0?@\)P#B4<_M8']H91Q*Q;S&<]EJDA3L!Z:N,*:T6MF):U+; M4K4/[KZ4EB!BVH,8T=8=DPK(SAUA9\^FKH7\C/S<$7XV.BB?G^G8+)G)FC)G M8EU$$SEBF![\8]NP.B,6AE%R?50^\@TQ1C_>/I'_5B7_LQS,E<>\;L!OV9%> M-,]>FH4\:TZ3Y&D>EJ/C7:LOZ)3T15V];[*7S]+'V*2$6D(E(1 MJ8A41"HB%9&J],HA4A&IK4DKWAN])?UHA7*-Y>>W7#"EF%,"8+6G=4P+J0I"K']>:1^Y,F_Y P'?=B_N#X MI^)J_?&U5UM>2 ?OW_6FSYA]ZV:^-QWONT$&:YD/6,C%8LH?#DBUV $7 MYRE.%G=0Q25$T*<.;U0LO;#LO/ZHR0/E(^&M[)'P;%,(8?_C]02P,$% @ JX)\ M6*V:G05& P 0@\ !$ !F;W)A+3(P,C0P,S(X+GAS9+576V_;(!1^G[3_ MP/R.K^G41$VK36VG2MTZ=9NTMXE@G* 1\("LR;\?8.,XU\7Q]H;A?!?@'')R M=;.<,_";2$4%'P=)& > <"QRRJ?C8*$@4IC2X.;Z]:NK-Q!^()Q(I$D.)BOP M7@J42YI/"?C\_%101D Z"+,P"2_2=-!:AM#"EVJD\(S,$=!(3HG^A.9$E0B3 M<3#3NAQ%T5Q(Q!%;:8I5B$64QND@SM)+8XF1.>'Z7LCY+2G0@NEQ\&N!&"TH MR0-@]L#5:*D:II>7E_ E"X6<&I(XB;Y_?/SBM'UL8:1.T*V"&>4_-ZB7$\D\ M>1;9Y0E2I/&Q$U];28;#8>16FU!#1(]04ZXTXIBTXW/= -K!%U&UZ$-S0C?C M%,'A5/R.S(+=8=8$:@GUJB1JOP^S'-EEBTEAG,$L\4B3'IO JF) _F5#2$E M]:'X9JD"F'0!P"8,XEQHI$UNNJEZLBPI+T0]8^;LB8[\+3R3 K@S'EG"<:#H MO&3V -W<3))B'-C;A_Z6?Y22A,:A#Y&"D2-78I;S;M3]%J*Q+OWKR'P5V-%6T\D_27DQ$F%9^QJ9S%BY5[C/I MJ(<#[]Q1#]OA=M!#%8L%UW+51;D-\1]]'"RD-#_AW2RT,:BQ[_+HXFKYE5S=&QA_6 MD"Q+9EH8+>3JWGR?7@)MEKLUR3D5T>ZH.YV1CZ_.Q_;CG8[F4"=_MGK?Z]G[ MM^60F;\AW;=:&W'-445V_0=02P,$% @ JX)\6*QZ((>U" !UD !4 M !F;W)A+3(P,C0P,S(X7VQA8BYX;6S-G&UOVS80Q]\/V'?@O#<;4-NUW0U( MT+C(LJ0(EB9!XF)/& 99HAUALAA0F-!F]["*)T>=);9_T@"^.X]V'Z[3?OO^OW/^(4 MTR#'$9H_HU\H"2(:1TN,;N]N%G&"T?C=8#(8#7X:C]_MF?M]WCV)T_^.^3_S M(,.(A4VSXTT6G_0>\OSQ>#A\>GH:/$T&A"Z'X[=O1\,_/EW=AP]X%?3C-,N# M-,0]Q/3'6=%X1<(@+\:\UWTSITGM8#+QP?5VVBQ[")7YHR3!=WB!^-_/=Y?:WD=# MKABF.+\*YCAA(8ON^?,C/NEE\>HQP77; \4+V$]"Z=8-S\X1S\[H9YZ=[W>> MAR[#6W*89B0/DG;&6?A3QZJ$<1_T=5NI-0WYNLTLLT6.7R'+>V'*,K&F(I0C:$5@E2*AO.2S( MX2IAX?@# 4[[G^][*(X@W;0X17_7#?^\'^Y&JL[NE(JU"&A8#X4=-@R_4@Q# MPFZ0CWE?F,F"DI4N]\20LBH#A:]C)$A03A#0;^B=KE])N%[A-)\QCU+I(5,U M!='D@!84PX4LR9\.+$$VK<\0/STL5&#.B3Y7(E+[BIHH8ZD\ /4[C7-V*3TC MJ]4ZCY+$89RSSZ2?V$,#C8-$PDAKJ0IDR*8*JZFDJ+TGI \I9BO@XPFWIQ]>8/I_1FL_MJQM+@(H!B62T'MJBZ(4M/==:$O-[PZFO" UXC22[-2FFGR ML%Y.6>2(1[](@J4$)6BKIBK9'+ 'H[@P+CO4 2WJIMM3Q,\/RRF<>6)(F$B@ M(*EQ,Y?,XX; 19R%0?(G#N@%:Y$_P36HI&T"1=7"CH$FW*8;Q,4'@G??KGT*_N,JJ$;U$AD2YH6 MJ :CMD&T[+B)9E&_([E"F!D0MW2#8KA6Q"*U,+V"5";77'0/U)ZG;)3/=W@9 M\R\ZTOPZ6,D(F235%&&) [*FF"[$:OSJ@ 7ET[(5[9H1;S\LK<8BD>:DBJQ" MRAI5JUI[(_6,+1(:))?L0][F-_P,HJK1"*PJ&F=8-5'=:54=FW&5]36O53LJ M#(A9ND"LKE;$(K40LY)4A+:IZ-ZHO8@3?+U>S97],YU98'7?[(RI&LN=4,&G M&(!(I!S F$.-RI1 0-M?1&WRS87$8,_7A1?9-G0+%!*W"I MU3I#VC *=V+U X+SV*^;>]8H15&]0 MH4.$HDJ+N+@+B\<. O+B*D$+R=A17$XO(\W;HCI?8;J,T^5'2I[RAS.R>@Q2 M^.';&?L,G,5\]95[-S#T6IE(/"!SQUT;NP76(=\-H*M=MI1OT,Y6;09V M G%]]8A=ID&X%;5$=C,,WK ^C2+&55;]N8I3/ *Y-N@$L$&=,]F&Z.YHP\[- M;$-]:KBKQC?U >)F=)-VXN'&5$=BF7*(<4 N0FX#QBM2/K:D?&Q)^=@+Y6.? ME(^_@O)Q ^6S)])-RL>VE,L%;Z!\W$2Y"L8K4CZQI'QB2?G$"^43GY1/OH+R M21/EK$@=O9I/;#F72][ ^:2)2UI[4HNQFSO,K[U:W<-K^3J!;PT= AEN4K@A1NL)'C5KKXA M "_9FF+[1O669'F0_!4_:K],,@DA;"5A6_""\5M#6/9N!;+82<&Y-"-F[\QW M0L9:0G";J@XA+NA!T,UX^'@'!H]-<0 #IFJR8DFEQ=@ #&C?EI!T@$DT[TR1)IVU=L7WQAJI4'HOC[O9+;!Y+"_T5*9ZXFHIH=Z-+% M8VU]/'" 1RN*2-^-)[/^" E M*G3F:D*JV>55 YI83B\:4'UJ7S,@2Z?%'T06:#3^8?XCJ@4'?M& KB+$G$41 M05FU?<5 4T$]('A-9C3@KV&\?U[-20+\DM2@J*8%*AQ8-$1TP1%VJR,24D^O M":I:4=G<@=^;FNI#&A,JD@D(:SAMBNR!3R&HQ IHJR8DV1QH!*.X<"@[U!$H MZJ8B>(=E#LX\,21,Y$R0U(292^;Q]GN^"1]8 3#P^R.31+H-BY(6;L50S#9N MQY+?IENR()_6K:AN[L#OCXQ%(LU)A>_.^TKY#@W5>C\'5^R(OXRX:HK+E_=. M_P=02P,$% @ JX)\6)\3PEL!!@ ]4 !4 !F;W)A+3(P,C0P,S(X M7W!R92YX;6S57%U/XS@4?5]I_T.V^]R&ILSL@&!&+ .C:AA P&H_7E9NXK;6 M)G;EI-#^^[53&VK'=M(!1I<7VN8>7]_C<_)UFW+T:57DT3WF)6'TN#<<[/4B M3%.6$3H[[BW+/BI30GJ?/O[\T]$O_?X73#%'%[-JVIQ&,Y' 'Y;UQ@N6HJJN>6OX:L)SG6 4 M/\[E1K,NNI$F6XPR0:OFK@%:?AP<%!7$+5>X.->28I%CO6V M.<=3=YZ<\\L0OG+U%GG:];:F.;Y15^^ MU-*&2KY\R546.SG^ :N\- MO^H=2BT81Q3EZXJDY2!EF^R?6;HL,*U.J%"N(M5Z3*>,%_6IH;UP 46BL&1_ M;Y1\J,L*Y]LN<\%Q*8!UY$)L,";#JPK3#&=Z.EGK,XC4T^J))T,&/W<8:)T#@9R3>2]JBF+#[\>\K$)<#)I*PX2BN=*9?:'/>< M,5&A9&3%XED*J3+-D%GEMHXGW*P8\51G$F\-$9NG:X6(%XB+ M?/UT3O)'_:><%;Z59,'2M\L[C(P,4<4B;'O3UY%2<&3C'G:A<+U%T7 MG6_OAZ\IX(FH-I,5G^=H9BGHC*EUL&+P- P5WR*B-52I. 2LHK;=XSGSLSB8 M>_9')\;:,2T,/'6[D.FXJUHIE-K)&U#[G)0IRO_&B)^++:5';P_*4KR!@JMY MF%!'U1M)E.ZC-Z/[QK?MRCMP3NT-''3U_:1VTM](HQRP#]@!FTO1TQ3 MQA>,U_QN!4U\RI:"S/J49>Z]O-,(PPDM(Z#Z8A>BG5S2DE!YY@-XS]RAU3@3 M;,F4;+Y4"9SL6["&3[Q8J [I1JZ3-[RIE"L.P+OB),L$T5*]7!"*ATY'!'"& M&YPXJ$YH)]7)!+ "Y\6>4?RK>7O$[]D!#!FBB7/)OHX"+[R6TB_3; M2;3PD#M_1O'UE>T5O^;LGFR>PO&J[X&Z+-" O=!F-HN9FADTHZ WPG4=M[< MY@2/ R;$>1#0$.#*NZGLM/OK#%II^.U!5?DU*RN4_T,6WO9!".A2W0("USY$ M:Q<'6'FT#R!W#^4YZX1CY%#>%=)/A!@A>.H&2F_1TQRI%83<$93/R.;7'":3.TG34M475DO2#,-3M85" MBZK-T5I5R#VW.X[D,_>WZV+",@M@%"KXD3 $[:=2(N\S@1:9,B=,7V$.5NE@AB'8E-"#R=.U#I M>$0V,VBEX3? S@K,9\*G7SA[J.:GK%@@ZK[Y#2*-NR$/$I[\W8EUNA_R)-)F M@-\4.UN)HQ8MB62Y>9S+[00OS+2! P;6 VV4NAG D46K#[D!]J"JWTF@[MSO&:WTA=[>N.9:VQ#3%]>]GY,^U^-5TVNB2M /50H6 \'3O M3*M%_U >[0/(/3*K_G%9+C'O[ 8OW.T)!QR\,]HH[N8/1S;MDN?VW([BQA)> MB WR7P]L(O*/_*G^Q_\!4$L! A0#% @ JX)\6#4\Z69"% H(8 !$ M ( ! &5F,C P,C,Y-S!?.&LN:'1M4$L! A0#% @ MJX)\6,O0A1VS60 $G ( !4 ( !<10 &5F,C P,C,Y-S!? M97@Y.2TQ+FAT;5!+ 0(4 Q0 ( *N"?%BMFIT%1@, $(/ 1 M " 5=N !F;W)A+3(P,C0P,S(X+GAS9%!+ 0(4 Q0 ( *N"?%BL M>B"'M0@ =9 5 " @ 9F]R82TR,#(T,#,R.%]P&UL4$L%!@ % 4 1P$ .B $ $! end XML 18 ef20023970_8k_htm.xml IDEA: XBRL DOCUMENT 0001829280 2024-03-28 2024-03-28 false 0001829280 8-K 2024-03-28 FORIAN INC. DE 001-40146 85-3467693 41 University Drive Suite 400 Newtown PA 18940 267 225-6263 false false false false Common Stock, $0.001 par value FORA NASDAQ true false